
Results
2
2 companies
Newron Pharmaceuticals
Market Cap: CHF 401.3m
A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.
NWRN
CHF 20.05
7D
-0.5%
1Y
105.2%
Cosmo Pharmaceuticals
Market Cap: CHF 1.9b
Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.
COPN
CHF 117.60
7D
-5.8%
1Y
85.5%